Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine.
about
The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorderAdrenoceptor blocking properties of atropine-like agents anisodamine and anisodine on brain and cardiovascular tissues of ratsAlpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animalsThe neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition.Targeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive DisordersStudies on some para-substituted clonidine derivatives that exhibit an alpha-adrenoceptor stimulant activityChanges in postnatal norepinephrine alter alpha-2 adrenergic receptor development.Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depressionMolecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders.Normal [3H]flunitrazepam binding to GABAA receptors in the locus coeruleus in major depression and suicidePrenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat.The thermogenic actions of alpha 2-adrenoceptor agonists in reserpinized mice are mediated via a central postsynaptic alpha 2-adrenoceptor mechanism.The effects of acute and chronic desipramine on the thermogenic and hypoactivity responses to alpha 2-agonists in reserpinized and normal miceChanges in [3H]-UK 14304 binding to alpha 2-adrenoceptors in morphine-dependent guinea-pigs.Influence of amineptine on changes of blood pressure evoked by norepinephrine and dopamine[3H]-Clonidine binding to alpha-adrenoceptors in membranes prepared from regions of guinea-pig kidney: alteration by monovalent and divalent cations.Clonidine distribution in the rat: temporal relationship between tissue levels and blood pressure response.[3H]-guanfacine: a radioligand that selectively labels high affinity alpha2-adrenoceptor sites in homogenates of rat brain.Genetic alteration of catecholamine specificity in transgenic mice.Once-daily treatment of ADHD with guanfacine: patient implications.Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man.Septal deafferentation increases hippocampal adrenergic receptors: correlation with sympathetic axon sprouting.Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.Binding of [3H]-prazosin and [3H]-dihydroergocryptine to rat cardiac alpha-adrenoceptors.The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.Mode of antinociceptive action of flupirtine in the rat.The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist.5-Methoxy-N,N-dimethyltryptamine-induced analgesia is blocked by alpha-adrenoceptor antagonists in rats.Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca(2+)]i.Role of cortical alpha-2 adrenoceptors in alcohol withdrawal-induced depression and tricyclic antidepressants.
P2860
Q24629736-BE131E86-3798-4CAA-88B4-3B4E0E595A51Q24673914-5064927F-478A-4B23-AAF9-52A19F6F7C2CQ24682060-D5A3D651-F9CF-4890-8380-12192488D15DQ27013979-6271B221-5585-4007-BC46-9F97FC2526A3Q28076907-3F288426-9ACB-4023-861D-F7CCBF4B4FDCQ28365730-1479C8C6-1ECD-43C1-8D02-8A0C84EDD96FQ30463333-6117A638-A7B9-4968-96D4-99323FE69FE1Q34065490-72B3696F-AC71-4C00-9DE0-AAB0A3A87356Q35028276-BD1DE45E-925A-416E-96A3-3653B7D99335Q35613815-1627745F-059F-4635-AA00-308534920D4EQ35713639-BEFC5A42-0639-4926-8BD0-F3DDF5D0B549Q35756126-57628338-743E-4E48-AD53-99A2E561DA10Q35756144-BBB4D973-4580-456F-86A5-C4BB8CE5D58BQ35873153-645772E6-DF4C-44E6-9F9A-012E6D9FA8E3Q35939213-D408F4E0-42EC-4752-86DF-6B04B09053DFQ36096933-688EDE94-C25E-429F-BE49-53219AF7B5A6Q36097007-C7165B87-5B7C-40EB-AB8A-55E4888914EFQ36128117-39FFC748-84C2-4369-9E30-E6888136F5B1Q36850820-C74841FE-2DED-4F58-8FBA-0B80D05A4E01Q36853970-893808E8-267B-45C2-B8BD-86ABD5BDD0ECQ36982147-3345133E-32A0-4CC3-AED1-FDE8B0C7131EQ37550241-947023BF-765E-4042-87CE-DCD581BF10BDQ37835904-14451D08-E64D-496C-9FA1-4C6A866E8D5FQ39933601-83A982F1-CAA0-418A-B456-53C638CDAD3EQ41570471-3D0C6551-459C-4075-AAB2-73394E801271Q41905541-C2D911F2-2E5D-4854-8A18-4C02902D05D0Q42132920-1598E675-9673-44EE-A4CE-79AB03833A7EQ42143540-8A5026B0-6278-41E2-9AAF-4711829661ECQ42256211-8D7111B2-0E7E-4C32-841A-CC0609F8F290Q47791795-03460224-C7DC-459F-BEC8-0AC41ED1E10A
P2860
Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Multiple apparent alpha-noradr ...... : effect of 6-hydroxydopamine.
@en
Multiple apparent alpha-noradr ...... : effect of 6-hydroxydopamine.
@nl
type
label
Multiple apparent alpha-noradr ...... : effect of 6-hydroxydopamine.
@en
Multiple apparent alpha-noradr ...... : effect of 6-hydroxydopamine.
@nl
prefLabel
Multiple apparent alpha-noradr ...... : effect of 6-hydroxydopamine.
@en
Multiple apparent alpha-noradr ...... : effect of 6-hydroxydopamine.
@nl
P2093
P1476
Multiple apparent alpha-noradr ...... : effect of 6-hydroxydopamine.
@en
P2093
Bechtel WD
U'Prichard DC
P577
1979-07-01T00:00:00Z